Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries

Hydroxyurea is widely used in high-income countries for the management of sickle cell disease (SCD) in children. In Kenyan clinical guidelines, hydroxyurea is only recommended for adults with SCD. Yet many deaths from SCD occur in early childhood, deaths that might be prevented by an effective, dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulaku, Mercy, Opiyo, Newton, Karumbi, Jamlick, Kitonyi, Grace, Thoithi, Grace, English, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812872/
https://www.ncbi.nlm.nih.gov/pubmed/23995076
http://dx.doi.org/10.1136/archdischild-2012-302387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3812872/
https://www.ncbi.nlm.nih.gov/pubmed/23995076
http://dx.doi.org/10.1136/archdischild-2012-302387

Ejemplares similares